Rituximab vs Low-Dose Mycophenolate Mofetil in Recurrence of Steroid-Dependent Nephrotic Syndrome in Children and Young Adults
Pietro Ravani, Francesca Lugani, Stefania Drovandi, Gianluca Caridi, Andrea Angeletti, Gian Marco Ghiggeri
Abstract
This randomized clinical trial examines the superiority of a single dose of rituximab vs low-dose mycophenolate mofetil in preventing the recurrence of steroid-dependent nephrotic syndrome in children and young adults.
Topics & Concepts
MedicineMycophenolateRituximabNephrotic syndromeInternal medicinePediatricsYoung adultLymphomaTransplantationRenal Diseases and GlomerulopathiesAutoimmune Bullous Skin DiseasesSystemic Lupus Erythematosus Research